scispace - formally typeset
D

Dinah S. Singer

Researcher at National Institutes of Health

Publications -  130
Citations -  5841

Dinah S. Singer is an academic researcher from National Institutes of Health. The author has contributed to research in topics: MHC class I & Major histocompatibility complex. The author has an hindex of 43, co-authored 124 publications receiving 5076 citations. Previous affiliations of Dinah S. Singer include Howard Hughes Medical Institute.

Papers
More filters
Journal ArticleDOI

BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain

TL;DR: The finding that BRD4 is an RNA polymerase II CTD Ser2 kinase implicates it as a regulator of eukaryotic transcription in cell cycle and transcription of oncogenes, HIV, and human papilloma virus.
Journal ArticleDOI

The Human Tumor Atlas Network: Charting Tumor Transitions Across Space and Time at Single-Cell Resolution

Orit Rozenblatt-Rosen, +373 more
- 16 Apr 2020 - 
TL;DR: The Human Tumor Atlas Network (HTAN), part of the NCI Cancer Moonshot Initiative, will establish a clinical, experimental, computational, and organizational framework to generate informative and accessible three-dimensional atlases of cancer transitions for a diverse set of tumor types.
Journal ArticleDOI

BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin

TL;DR: It is reported that BRD4 is a histone acetyltransferase (HAT) that acetylates histones H3 and H4 with a pattern distinct from those of other HATs, and mediates chromatin decompaction by acetylating and evicting nucleosomes at target genes, thereby activating transcription.
Journal ArticleDOI

RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription.

TL;DR: A mechanism through which the transcription machinery directly controls topoisomerase 1 (TOP1) activity to adjust DNA topology throughout the transcription cycle is reported, which promises to elicit new strategies to intercept pathological gene expression.